Resistance and support
1,483.02
![](https://www.icicidirect.com/Content/images/graph17.png)
Financials( ₹ in Cr) | Cipla Ltd | Sun Pharmaceuticals Industries Ltd | Divis Laboratories Ltd | Zydus Lifesciences Ltd | Dr Reddys Laboratories Ltd |
---|---|---|---|---|---|
Price | 1,480.80 | 1,520.85 | 4,596.45 | 1,073.95 | 6,402.35 |
% Change | -0.01 | 0.30 | 1.64 | 1.60 | 2.67 |
Mcap ₹ Cr | 119,554.91 | 364,902.86 | 122,021.50 | 108,064.50 | 106,802.72 |
Revenue TTM ₹ Cr | 15,790.60 | 43,885.68 | 7,767.51 | 17,237.40 | 24,669.70 |
Net Profit TTM ₹ Cr | 2,513.47 | 8,560.84 | 1,823.38 | 1,997.30 | 4,507.30 |
PE TTM | 28.08 | 36.50 | 76.24 | 28.04 | 19.16 |
1 Year Return | 46.72 | 48.84 | 27.62 | 84.38 | 27.39 |
ROCE | 14.76 | 16.79 | 19.30 | 16.25 | 25.99 |
ROE | 10.66 | 16.46 | 14.89 | 14.05 | 21.21 |
Equity Capital: 24,638.09 Cr FV: 2.00
Period | MF Net Purchase / (sold) | FII Net |
---|---|---|
LAST 1M | 29,542.69 | 26,564.54 |
LAST 3M | 107,300.08 | -872.81 |
LAST 6M | 187,950.75 | 839.71 |
LAST 12M | 304,454.24 | 86,051.23 |
Date | Action Type | Ratio |
---|---|---|
Jul 21, 2023 | Dividend | 425 |
Aug 08, 2022 | Dividend | 250 |
Cipla Limited is a pharmaceutical company having a market capitalization of Rs. 73,307.57 crores as of 18th August 2021. The company was incorporated within the year 1935. It reported its consolidated revenue at Rs. 5,504.35 for the quarter ended June 2021. The Bombay Stock Exchange (BSE) and National Stock Exchange have assigned the number 500087 and scrip code CIPLA, respectively. As of 18th August 2021, the shares of Cipla were trading at Rs. 908.85.
Cipla is headquartered in Mumbai and produces products for various therapeutic areas, including cardiology, children’s health, dermatology & cosmetology, diabetes, HIV/AIDS, infectious illnesses & critical care, malaria, and so on. The drug company primarily develops medicines to treat respiratory, disorders, arthritis, diabetes, weight control and depression, and other medical conditions. Cipla is the third-largest drug company within the country and is present in most countries within the European region, with DTMs in Germany, Norway, UK, and Spain. The company’s promoters hold a 36.72% stake of the total shareholding in the company in June 2021 as against 36.68% in June 2020 with zero pledge. However, the mutual funds holding has also decreased in the last 12 months, decreasing from 16.29% in June 2020 to 13.36% in June 2021, and over the last 3 months, it has decreased 1.28%.
In June 2021, consolidated total revenue from operations grew 26.64% to Rs. 5,504.35 crores, against Rs. 4,346.16 crores within the corresponding quarter last year. The Indian major pharmaceutical has posted a 23.67% increase in the consolidated net profit of Rs. 714.72 crores, on strong sales performance during June 2021, it had posted a net profit of Rs. 577.91 Crores within the corresponding period of the previous fiscal. EBITDA rose 28% to Rs. 1,346 crores in June 2021, from Rs. 1,049 crores in June 2020. EBITDA margin improved 32 basis points to 24.5%, as against 24.1% in the year-ago period. EPS of the company was Rs. 8.86 as compared to Rs. 5.13 in March 2021. Cipla’s shares closed at 908.85 (NSE) on 18th August 2021 and have returned 18.83% over the last 12 months.
Cipla House Peninsula Buss Par, Ganpatrao Kadam Mg Lower Parel, Mumbai, Maharashtra, 400013
Tel | : | 91-22-24826000 |
: | cosecretary:cipla.com, contactus:cipla.com | |
Website | : | http://www.cipla.com |
Karvy Computershare Pvt Ltd
AGM Date (Month) | : | Aug |
Face Value Equity Shares | : | 2 |
Market Lot Equity Shares | : | 1 |
BSE Code | : | 500087 |
NSE Code | : | CIPLA |
Book Closure Date (Month) | : | |
BSE Group | : | A |
ISIN | : | INE059A01026 |
You can buy Cipla Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Cipla Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jun 28, 2024 03:59 PM the closing price of Cipla Ltd was Rs.1,480.80.
The latest PE ratio of Cipla Ltd as of Jun 28, 2024 03:59 PM is 28.08
The latest PB ratio of Cipla Ltd as of Jun 28, 2024 03:59 PM is 0.22
The 52-week high of Cipla Ltd share price is Rs. 1,582.00 while the 52-week low is Rs. 996.50
According to analyst recommendations, Cipla Ltd Share has a "Buy" rating for the long term.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 28, 2024 03:59 PM, the market cap of Cipla Ltd stood at Rs. 119,554.91 Cr.